Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.

Published Date: 11 Dec 2023

USA: Glucagon-like peptide 1 (GLP-1) was found to be more effective in reducing the risk of colorectal cancer (CRC) in a nationwide cohort study.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

It Is Not Just the Royals Who Go Through Cancer.

3.

African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis

4.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

5.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot